Immune Therapeutics Clears Critical Certification Milestone
February 02, 2017 09:40 ET
|
Immune Therapeutics, Inc.
Immune Therapeutics Receives Approval for Lodonal™ from theDominican Republic’s Ministry of Health and Social Assistance ORLANDO, Fla., Feb. 02, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics,...
UPDATE -- Immune Therapeutics Issues Special Letter to Shareholders
January 30, 2017 10:48 ET
|
Immune Therapeutics, Inc.
Company Expects to Report Initial Revenues in First Half of 2017 and Achieve Profitability by Year-End Company to Host Investor Conference Call to Discuss Positive Developments ORLANDO, Fla.,...
Immune Therapeutics Issues Special Letter to Shareholders
January 30, 2017 08:40 ET
|
Immune Therapeutics, Inc.
Company Expects to Report Initial Revenues in First Half of 2017 and Achieve Profitability by Year-End Company to Host Investor Conference Call to Discuss Positive Developments ORLANDO, Fla.,...
Immune Therapeutics Redeems $656,250 Convertible Note; Company Actively Working to Strengthen Balance Sheet by Year End
November 15, 2016 09:06 ET
|
Immune Therapeutics, Inc.
ORLANDO, Fla., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN) a clinical-stage biotech company providing immunotherapy solutions for the treatment of autoimmune...
Immune Therapeutics, Inc. Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
June 15, 2016 14:46 ET
|
Immune Therapeutics, Inc.
ORLANDO, Fla., June 15, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biotech company providing immunotherapy solutions for the treatment of infectious and...
Lodonal™ Expected to Receive International Exposure at the World Health Assembly, one of the World’s Leading Health Forums
May 18, 2016 14:05 ET
|
Immune Therapeutics, Inc.
ORLANDO, Fla., May 18, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biotech company providing immunotherapy solutions for the treatment of infectious and...
Immune Therapeutics Receives NAFDAC Approval for Lodonal(TM) in Nigeria: Approval Follows Successful Recent Bridging Study
April 27, 2016 10:19 ET
|
Immune Therapeutics, Inc.
ORLANDO, Fla., April 27, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN) (the “Company”), a clinical-stage biotech company providing immunotherapy solutions for the treatment...